MED-EL USA announces FDA approval of SONNET 3 audio processor with built-in direct streaming, compact design and enhanced features.

A new study from Oregon Health & Science University is the first to suggest that binaural pitch fusion—a process that ...

Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on providing hearing loss sufferers with innovative solutions today announces additional patents for its growing ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Echoes of US President Donald Trump’s decision to junk diversity, equity and inclusion (DEI) laws have rippled through ...

ASX health stocks have fallen this week as Chemist Warehouse hits the bourse through its merger with Sigma Healthcare.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear Limited (CHEOF – Research Report) ...

The S&P/ASX 200 hit an all time high on February 14, 2025 but AMP and Cochlear fell heavily on results, ... Read More The ...

Cochlear (ASX: COH) shares are trading at the lowest level since December 2023 after the company reported a ...

Cochlear shares were on track for their worst session in five years on Friday, after the Australian hearing implants maker reported first-half profit below estimates and forecast annual earnings at ...

Cochlear (ASX:COH) will pay an 8% higher dividend, with profits up 7% for the half year to the end of 2024 despite falling ...

Discover Cochlear Limited's Q2 2025 earnings insights: strong implant growth, upcoming product launches, and strategic investments amid Services ...